Breakingviews TV: Rare stakes

United States News News

Breakingviews TV: Rare stakes
United States Latest News,United States Headlines
  • 📰 Breakingviews
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Watch: Altaba and Naspers won the lottery from their tech investment, but these gains comes with problems, jennifersaba explains.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Breakingviews /  🏆 470. in US

 

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Breakingviews TV: Broken OathBreakingviews TV: Broken OathFalling revenue at Verizon’s online media business, cobbled together from bits of Yahoo and AOL, poses a dilemma for newish CEO Hans Vestberg. Jennifer Saba says he will have to either double down to build scale in the space or write down the...
Read more »

Breakingviews TV: OMGEBreakingviews TV: OMGELawrence Culp’s first quarter-end as GE chief executive came with a huge dividend cut and a $22 billion writedown of the company’s power assets. Shareholders have waited a long time for the conglomerate to fix its myriad problems. They’re still...
Read more »

Breakingviews TV: Amazon HQ2+1Breakingviews TV: Amazon HQ2+1The tech giant has chosen not one new headquarters but two – New York and Arlington, Virginia. That brings more high-paying jobs to wealthy cities with tight labor markets. While Tennessee gets some goodies too, it’s mostly a triumph for the coastal...
Read more »

Breakingviews TV: Tencent timeBreakingviews TV: Tencent timeThe Chinese tech titan's third-quarter earnings rose 30 percent, defying pessimistic expectations as it weathers a regulatory crackdown on video games. Robyn Mak explains to Pete Sweeney what went right.
Read more »

Breakingviews TV: Drug dreamsBreakingviews TV: Drug dreamsModerna’s hoped-for $8 bln IPO valuation is a rich antidote to the funk hitting tech stocks. Rob Cyran explains that although the biotech firm’s technology is promising, it has no drugs near commercial readiness. That’s all the more reason to grab...
Read more »



Render Time: 2026-04-02 13:19:32